Yeah, we were quite surprised when I spoke to them and discovered this. In the future we might ask them to use all and increase the cycles to 14 or 15. That would explain A LOT of reasons why we are struggling with our samples (RNA, not so much for DNA).
-
-
Hi jteeee2,
I just wanted to check back in with you and say thank you. We did some testing in the lab and both the primers / Taq you recommended appeared to work well. We submitted that to our Sequencing CORE and we were able to save over 2/3's of those 68 samples. That a huge relief!!! So instead of all 4 out of 72, we now have material for 49. We have a plan to save those other 23 samples and we are asking them to increase the cycles from 12 for future RNA/FFPE runs.
Thank you so much.
SueComment
-
Glad to hear things are improving. Best of luck getting those last 23 samples made into libraries.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment